Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories reports 33% rise in Q2 consolidated net profit

Date: 27-10-2023

Dr. Reddy's Laboratories has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 6.84% rise in its net profit at Rs 1192.60 crore for Q2FY24 as compared to Rs 1116.30 crore for the same quarter in the previous year. Total income of the company increased marginally by 1.27% at Rs 5061.80 crore for Q2FY24 as compared Rs 4998.30 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 33.03% rise in its net profit at Rs 1482.20 crore for the quarter under review as compared to Rs 1114.20 crore for the same quarter in the previous year. Total income of the company increased by 13.26% at Rs 7217.60 crore for Q2FY24 as compared Rs 6372.60 crore for the corresponding quarter previous year.